Pharmafile Logo
Pharmafocus logo
Advanced Search

Further six officials fired from China FDA

August 21, 2018
Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal

A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …

News
30614937102_31ec4db2fa_z

Prozac prevents cognitive decline during normal aging process, study shows

August 21, 2018
Manufacturing and Production MIT, Picower Institute, Prozac, antidepressants, mice, neuroscience

A study conducted by MIT’s Picower Institute for Learning and Memory has reinforced the notion that loss in the capacity …

News
Image Credit: Bristol-Myers Squibb

FDA approves Bristol Myers Squibb’s Opdivo in small-cell lung cancer

August 20, 2018
Sales and Marketing Bristol-Myers Squibb, FDA, approval, bristol myers squibb, lung cancer, opdivo

The FDA has approved Bristol Myers Squibb’s Opdivo (nivolumab) for patients with metastatic small-cell lung cancer (SCLC), as the first …

News
ipos0_l

Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration

August 20, 2018
Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma

Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …

News

Thyroid medication recalled after Chinese supplier fails inspection

August 20, 2018
Sales and Marketing China, FDA, recall, thyroid, westminster

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly …

News

More children suffering from type 2 diabetes in England and Wales

August 20, 2018
Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people

The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …

News

Chinese regulators approve Roche’s Alecensa in regulatory shift

August 20, 2018
Sales and Marketing Cancer, China, Roche, approval, lung cancer

China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …

News
andrew_cheng

Gilead CMO announces departure alongside two new exec appointments

August 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …

Appointment
hero-plus

FDA approves first-ever generic EpiPen versions, courtesy of Teva

August 17, 2018
Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma

The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …

News
genentech_web

Genentech to axe 223 staff from San Francisco HQ

August 17, 2018
Manufacturing and Production, Medical Communications Genentech, Roche, layoffs, pharma

Roche subsidiary Genentech has announced plans to axe 223 employees from its headquarters in San Francisco, California, beginning on 31 …

News

CCP fire provincial official and investigate drug regulator in response to Changsheng vaccine scandal

August 17, 2018
Medical Communications China, Vaccine, changsheng, drug safety, regulation

The Chinese government has fired a senior provincial official and is probing a former senior drug regulator in response to …

News

GSK announces closure of Sligo, Ireland facilties

August 17, 2018
Medical Communications GSK, GlaxoSmithKilne, Ireland, Sligo, closure, manfuacturing

British multinational GlaxoSmithKline has announced the closure of its manufacturing facilities in Sligo, Ireland. The company is set to wind …

News
blood-75301_640

“Triple pill” blood pressure combo proves more effective, safe than standard care

August 16, 2018
Research and Development blood pressure, heart attack, heart disease, pharma, triple pill

A “triple pill” combining three established and effective drugs at low dosage levels could prove much more effective in treating …

News
6813384933_1fb31d73fb_z

Ibalisumab effective in in treating multidrug resistant HIV

August 16, 2018
Research and Development AIDS, HIV, multidrug resistance, phase 3

The monoclonal antibody Ibalizumab has shown significant antiviral activity against multidrug resistant HIV infections, according to the results of a …

News
1280px-old_surgical_hospital_drummond_street

Regenerative process could be restored in liver after severe injuries, study shows

August 16, 2018
Research and Development Edinburgh University, liver, mice, research, transplants

Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …

News

Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines

August 16, 2018
Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma

Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …

News
dubai

Indian biotech owner detained in Dubai over £550m fraud allegations

August 16, 2018
Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud

Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …

News

Realm Therapeutics shares halved after failure of Phase 2 study

August 15, 2018
Research and Development London, Shares, atopic dermatitis, phase 2, stock market

Shares in the London-listed Realm Therapeutics plummeted on Monday after the company reported that a Phase II study of the …

News

Janssen and ViiV’s monthly injectable HIV combo proves non-inferior to daily standard of care

August 15, 2018
Research and Development HIV, Janssen, ViiV Healthcare, pharma

Janssen and GSK’s ViiV Healthcare have unveiled strong new Phase 3 data on its two-drug regimen, injected once a month, …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026